- Analysts
- Dividend Payments
- Government Awards
- Insiders
- Lobbying Expenses
- Segment Revenues
- Shareholder Structure
- Supply / Portfolio
- Valuation Models [Soon]
- Board & Officers
- Business Intelligence
- Employee Voice
- ESG Scores [Soon]
- Mergers and Acquisitions
- Qualified Risks
- Clinical Trials [Soon]
- H1B/PERM Strategy
- Industry H&T [Soon]
- Macro
- News
- Patents / Trademarks [Soon]
- Peer Performance
- Relevant Disputes [Soon]
Absci Corporation
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of b…
Shareholders
Major Shareholders · StructureBreakdown
The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public. for Absci Corporation
Beneficial Owners Beta
Beneficial owners who control a significant portion of the shares outstanding.
| Owner | Shares | Equivalence - $2.86 per share | Last Form/Filing | Last Transaction |
|---|---|---|---|---|
| 10% Holder | ||||
| - No data - | ||||
| Officers/Directors Below 10% | ||||
| - No data - | ||||
Shareholder Breakdown
The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public.
It's perfect to get a quick briefing regarding the shareholder structure of Absci Corporation
Short
We source Fail-To-Deliver data every month, directly from the SEC.